Rachel BONIFACE BELLIER

Information

Research Support

Jean MOSSER Group

+33 (0)2 23 23 45 72

CHU Pontchaillou (BMT-HC) - Génomique Médicale / P31611

Major publications

  • Integrative DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.
    Etcheverry A, Aubry M, Idbaih A, Vauleon E, Marie Y, Menei P, Boniface R, Figarella-Branger D, Karayan-Tapon L, Quillien V, Sanson M, de Tayrac M, Delattre JY, Mosser J.
    PLoS One. 2014 Sep.

    Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas.
    De Tayrac M, Saikali S, Aubry M, Bellaud P, Boniface R, Quillien V, Mosser J.
    PLoS One. 2013 Sep.

    DsRed-mediated oligomerization stabilizes HMGB1 on chromatin in vivo and on DNA in vitro.
    Messmer M, Klein C, Boniface R, Gnädig NF, Lecerf M, Barnay-Verdier S, Maréchal V.
    Biochimie. 2013 Apr.

    DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
    Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, Quillien V, Mosser J.
    BMC Genomics. 2010 Dec.

    High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.
    Thierry S, Gozlan J, Jaulmes A, Boniface R, Nasreddine N, Strauss F, Maréchal V.
    AIDS. 2007 Jan.

    In vivo studies of translational repression mediated by the granulocyte-macrophage colony-stimulating factor AU-rich element.
    Grosset C, Boniface R, Duchez P, Solanilla A, Cosson B, Ripoche J.
    J Biol Chem. 2004 Apr.

Subscribe to our newsletter